ArticleMicrosystems & nanoengineering2026
Magnetically guided biohybrid microrobots with multimodal locomotion for barrier penetration and multifunctional tumor treatment.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hierarchically Engineered Magnetic-Enzymatic Microrobots with Stimuli-Induced Disassembly for Controlled Navigation and Mucosal Penetration in 3D Lung Fibrosis Models.Advanced healthcare materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Penetrating biological and physical barriers within the body is essential for microrobots to access target sites and achieve effective therapeutic outcomes. However, synthetic microrobots exhibit limited deformability and dynamicity, which are required to navigate tight and complex microenvironments. Here, by leveraging the soft, deformable body of Euglena gracilis, we develop a novel biohybrid microrobot platform that integrates magnetic architectures for controlled propulsion, deformation, and multi-modal locomotion. This design not only preserves the natural motility of microalgae but also leverages their intrinsic therapeutic properties, including chlorophyll-dependent photodynamic therapy (PDT) and immune modulation through E. gracilis natural products. Our biohybrid microrobots navigate through dense three-dimensional biological matrices and around tumor spheroids, exhibiting targeted delivery to tumor regions under both magnetic control and autonomous tumor tropic behavior. This multi-functional platform combines adaptive locomotion, controllable and chemotactic guidance, offering a new paradigm for precision medicine without the need for exogenous drug loading, and has the potential to become a versatile future solution for tumor targeting and dynamic, adaptive treatment in complex medical environments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.